Closure After Total Shoulder Arthroplasty: Prineo vs Dermabond
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03899753|
Recruitment Status : Not yet recruiting
First Posted : April 2, 2019
Last Update Posted : August 5, 2020
The objective is to compare two types of wound closure after total shoulder arthroplasty to determine which closure is faster, and subsequently if there are different outcomes between the two types of closures.
The objective of this study is to compare two types of wound closure after total shoulder arthroplasty procedures. A single fellowship trained shoulder surgeon will perform all procedures. It is hypothesized that participants who undergo an 2-Octyl Cyanoacrylate (OCA) mesh closure will have a faster closure time, lower cost, non-inferior complication rate, and non-inferior satisfaction scores with respect postoperative follow up and scar appearance.
Participants in the OCA mesh cohort will be compared to participants who have a closure with a running monocryl suture and dermabond. This investigation seeks to determine if OCA closure mesh closure is non-inferior to monocryl suture and dermabond in terms of operative time, cost, complications, and aesthetic appearance.
If the hypothesis is confirmed, this study will suggest that a OCA mesh closure may be used for total shoulder arthroplasty surgeries as an alternative to current conventional closures and may provide a cost benefit.
|Condition or disease||Intervention/treatment||Phase|
|Shoulder Arthritis Shoulder Arthropathy Associated With Other Conditions||Device: 2-Octyl Cyanoacrylate and Mesh Device: 2-Octyl Cyanoacrylate||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||
* Prospective Randomized Design
o After determining a participant's eligibility for inclusion, participant will be randomized to the OCA mesh group or monocryl with dermabond group. After surgery, both groups will be seen at the 2 week, 6 week, and 3 month appointments
|Masking:||Double (Participant, Investigator)|
|Masking Description:||Sealed envelop determining which arm the participant is assigned to|
|Official Title:||Closure After Total Shoulder Arthroplasty: Subcuticular Closure With 2-Octyl Cyanoacrylate Versus 2-Octyl Cyanoacrylate With A Self-Adhering Mesh (Dermabond Prineo)|
|Estimated Study Start Date :||August 1, 2020|
|Estimated Primary Completion Date :||November 2020|
|Estimated Study Completion Date :||December 2020|
Experimental: 2-Octyl Cyanoacrylate and mesh
The wound will be closed with 2-Octyl Cyanoacrylate and a mesh
Device: 2-Octyl Cyanoacrylate and Mesh
2-Octyl Cyanoacrylate and a mesh will be applied to final closure of wounds after undergoing a Total Shoulder Arthroplasty
Other Name: Prineo
Active Comparator: 2-Octyl Cyanoacrylate
The wound will be closed with just 2-Octyl Cyanoacrylate
Device: 2-Octyl Cyanoacrylate
Incisions will be closed with 2-Octyl Cyanoacrylate after undergoing a Total shoulder arthroplasty
Other Name: Dermabond
- Time for Incision Closure [ Time Frame: During surgery (approximately 40 minutes) ]A stopwatch will be used to measure the time it takes for the incision to be closed. When the surgical implants are in place and irrigation is complete, the surgeon will announce that he will start the closure and a nurse will start the stopwatch to measure how long it takes for the surgeon to close the incision.
- Cost of Closure [ Time Frame: Immediately post surgery ]Cost of closure will be assessed by the cost of the time in the operating room and the cost of materials used to close the incision
- Wound Appearance [ Time Frame: At each follow up visit up to 3 months after surgery ]The surgeon and participant will fill out the Patient and Observer Scar Assessment Scale (POSAS). This is a survey used to assess the participant and the surgeons opinion of the appearance of the wound. The Patient and Observer Scar Assessment Scale (POSAS) is a questionnaire that was developed to assess scar quality. It consists of two separate six-item scales (Observer Scale and Patient Scale), both of which are scored on a 10-point rating scale. Each questionnaire consists of 7 questions, each graded 1 through 10. The minimum score is 7 (most like normal skin) and the maximum score is 70 (very different from normal skin). The observer is the surgeon. The observer and patient scores can then be added together to determine the collective score.
- Dehiscence [ Time Frame: At each follow up visit up to 3 months after surgery ]The wound will be assessed for dehiscence (incision opening) which will be recorded as a "yes or no". A dehiscence is defined as exposure of the underlying subcutaneous fat secondary to failure of the epidermal healing and may be accompanied by persistent wound drainage. It will be assessed by the length of the opening in centimeters and then normalized against the length of the entire incision. Furthermore, the number of wounds that open will be reported
- Wound drainage [ Time Frame: At first post operative visit ]Dressing for each participant after surgery will be regulated and changed by the surgeon at the first post op visit. Drainage will be measured by outlining the drainage on gauze onto graph paper and measuring the area as previously validated in prior studies
- Superficial Infection [ Time Frame: At each follow up visit up to 3 months after surgery ]Number of wounds with superficial skin infections will be reported
- Deep wound infection [ Time Frame: At each follow up visit up to 3 months after surgery ]Number of deep wound infections found will be reported
- Number of wounds that require post operative intervention [ Time Frame: At each follow up visit up to 3 months after surgery ]Will report the number of wounds that require post operative intervention
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03899753
|Contact: Konrad Gruson, MDemail@example.com|
|Contact: Brandon Tauberg, MDfirstname.lastname@example.org|
|Principal Investigator:||Konrad Gruson, MD||Montefiore Medical Center|